NZ596419A - Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders - Google Patents

Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders

Info

Publication number
NZ596419A
NZ596419A NZ596419A NZ59641910A NZ596419A NZ 596419 A NZ596419 A NZ 596419A NZ 596419 A NZ596419 A NZ 596419A NZ 59641910 A NZ59641910 A NZ 59641910A NZ 596419 A NZ596419 A NZ 596419A
Authority
NZ
New Zealand
Prior art keywords
disorders
fibrosis
treatment
ocular
scarring
Prior art date
Application number
NZ596419A
Other languages
English (en)
Inventor
Ian Alexander Mcdonald
Diego Silva
Alan D Robertson
Original Assignee
Pharmaxis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaxis Ltd filed Critical Pharmaxis Ltd
Publication of NZ596419A publication Critical patent/NZ596419A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ596419A 2009-04-28 2010-04-28 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders NZ596419A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17341609P 2009-04-28 2009-04-28
PCT/IB2010/000960 WO2010125445A1 (en) 2009-04-28 2010-04-28 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders

Publications (1)

Publication Number Publication Date
NZ596419A true NZ596419A (en) 2014-01-31

Family

ID=43031758

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ596419A NZ596419A (en) 2009-04-28 2010-04-28 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders

Country Status (10)

Country Link
US (1) US8557783B2 (enExample)
EP (1) EP2424542A4 (enExample)
JP (1) JP2012525369A (enExample)
KR (1) KR20120049183A (enExample)
AU (1) AU2010243314C1 (enExample)
CA (1) CA2760253A1 (enExample)
IL (1) IL215990A0 (enExample)
NZ (1) NZ596419A (enExample)
SG (1) SG175816A1 (enExample)
WO (1) WO2010125445A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014078655A1 (en) * 2012-11-15 2014-05-22 Tufts University Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor
PL3833358T3 (pl) * 2018-08-10 2024-03-04 New York University Zastosowanie ligandów agonistycznych receptora igf-2 w leczeniu zespołu angelmana i autyzmu
MX2021001596A (es) 2018-08-10 2021-06-08 Univ New York Uso de manosa-6-fosfato y sus modificaciones para mejorar la memoria y reducir el daño mental.
US20220023434A1 (en) 2018-12-19 2022-01-27 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional Molecules for Lysosomal Targeting and Related Compositions and Methods
CN113368106B (zh) * 2020-02-25 2023-09-29 渐宽(苏州)生物科技有限公司 艾托莫德用于防治特发性肺纤维化的药物中的用途
CN113288890B (zh) * 2021-06-21 2022-02-22 南方医科大学南方医院 N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用
JP2024524614A (ja) 2021-07-14 2024-07-05 ライシア セラピューティクス， インコーポレイテッド Ａｓｇｐｒ細胞表面受容体結合化合物及びコンジュゲート

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ872300A0 (en) 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
ATE440103T1 (de) * 2003-05-20 2009-09-15 Pharmaxis Pty Ltd Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheiten
FR2930943B1 (fr) 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese
FR2930942B1 (fr) 2008-05-07 2011-03-04 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose activateurs de l'angiogenese

Also Published As

Publication number Publication date
KR20120049183A (ko) 2012-05-16
JP2012525369A (ja) 2012-10-22
EP2424542A4 (en) 2012-12-19
US20120045455A1 (en) 2012-02-23
AU2010243314C1 (en) 2015-11-12
EP2424542A1 (en) 2012-03-07
WO2010125445A1 (en) 2010-11-04
US8557783B2 (en) 2013-10-15
IL215990A0 (en) 2012-01-31
AU2010243314A1 (en) 2011-12-01
SG175816A1 (en) 2011-12-29
AU2010243314B2 (en) 2015-07-02
CA2760253A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
EP2670486A1 (en) Treatment for lipodystrophy
WO2012035421A3 (en) Pyridine compounds and the uses thereof
EA201391263A1 (ru) Комбинированные терапии гематологических опухолей
WO2010088050A3 (en) Bicyclic pyrazolo-heterocycles
GB201109620D0 (en) Injection apparatus
MX2013003693A (es) Fijador de tejido.
PH12015502012A1 (en) Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
MX376894B (es) Nuevos compuestos de acido carboxilico utiles para inhibir la sintasa-1 de prostaglandina microsomal e2.
WO2014144137A3 (en) Tissue resection snares
EP2194888A4 (en) TREATMENT OF DYSFUNCTIONAL HEARTWEAR
RU2012107109A (ru) Бициклическое соединение и его применение для медицинских целей
WO2012173682A3 (en) Compounds and methods for the treatment of isocitrate dehydrognase related diseases
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
PH12012501358A1 (en) Treatment method
EA201200318A1 (ru) Гетероциклические оксимы
WO2012071509A3 (en) Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
JOP20120351B1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
WO2014126944A3 (en) Inhibitors of the renal outer medullary potassium channel
WO2011026911A8 (en) Bipyridines useful for the treatment of proliferative diseases
WO2014099633A3 (en) Inhibitors of the renal outer medullary potassium channel
RU2013129484A (ru) Алкиновые и алкеновые производные в качестве модуляторов рецептора сфингозин 1-фосфата-1
MX2012002758A (es) Pirazinil-piridinas utiles para el tratamiento de enfermedades proliferativas.
WO2013101845A3 (en) Adjustable resection device
WO2015095097A3 (en) Inhibitors of the renal outer medullary potassium channel
NZ597866A (en) Therapeutic lactams

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 28 APR 2017 BY DAVIES COLLISON CAVE

Effective date: 20140502

LAPS Patent lapsed